Physician profile
Stacey M Cook
NPI 1265823306
$69,113.37
in general payments reported to CMS, 2019-2025
13 companies · $39K in 2025
The $39K reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $433 · 2022: $3,916 · 2023: $11K · 2024: $15K · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $32K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Consulting Fee: $15K · Travel and Lodging: $2,243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $31,795.92 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,500.00 |
| Consulting Fee | $15,226.00 |
| Travel and Lodging | $2,242.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $27,934.63 | 2023-2025 | M22 |
| Merz North America, INC. | $21,579.22 | 2022-2025 | Xeomin |
| Revance Therapeutics, INC. | $16,903.77 | 2024-2025 | Daxxify |
| Abbvie INC. | $1,308.43 | 2022-2024 | |
| Allergan, INC. | $784.61 | 2021-2022 | |
| Musculoskeletal Transplant Foundation INC. | $175.33 | 2022 | |
| Galderma Laboratories, L.P. | $105.73 | 2022-2023 | |
| Regeneron Healthcare Solutions, INC. | $102.86 | 2021 | |
| Incyte Corporation | $88.37 | 2021-2022 | |
| Leo Pharma INC. | $58.40 | 2023 | Adbry |
| Mentor Worldwide LLC | $27.32 | 2022 | |
| Alk-Abello, INC | $26.83 | 2022 | |
| Lilly USA, LLC | $17.87 | 2024 | Zepbound, Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.